Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan-Reference-Cited by-同舟云学术

Comparative risk of hospitalized infection between biological agents in rheumatoid arthritis patients: A multicenter retrospective cohort study in Japan

Published:2017-06-08 Issue:6 Volume:12 Page:e0179179
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Mori Shunsuke^ORCID,Yoshitama Tamami,Hidaka Toshihiko,Sakai Fumikazu,Hasegawa Mizue,Hashiba Yayoi,Suematsu Eiichi,Tatsukawa Hiroshi,Mizokami Akinari,Yoshizawa Shigeru,Hirakata Naoyuki,Ueki Yukitaka

Funder

National Hospital Organization (NHO), Japan

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference56 articles.

1. Use of biologics in rheumatoid arthritis: current and emerging paradigms of care;JR Curtis;Clin Ther,2011

2. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update;JS Smolen;Ann Rheum Dis,2014

3. Efficacy of biological disease-modifying antirheumatic drugs: a systematic literature review informing the 2013 update of the EULAR recommendations for the management of rheumatoid arthritis;JL Nam;Ann Rheum Dis,2014

4. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis;JA Singh;Arthritis Rheumatol,2016

5. Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials;T Bongartz;JAMA,2006

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The use of biological and targeted synthetic basic anti-inflammatory drugs in elderly patients with rheumatoid arthritis: for or against;Problems of Geroscience;2024-06-30

2. Incidence of serious infections in the working‐age Japanese adult population with rheumatoid arthritis treated with tumor necrosis factor‐α inhibitors and interleukin‐6 inhibitors: A nationwide retrospective cohort study;Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy;2024-06-12

3. Real-world retention rates of biologics in patients with rheumatoid arthritis;Scientific Reports;2023-12-01

4. Elderly-Onset Rheumatoid Arthritis: Characteristics and Treatment Options;Medicina;2023-10-23

5. Drug retention of biologics and Janus kinase inhibitors in patients with rheumatoid arthritis: the ANSWER cohort study;RMD Open;2023-08